About the company
ReSynapse Therapeutics is a precision neuroscience company aiming to create fast-acting, long-lasting therapeutics that address critical unmet needs in depression and anxiety. We develop a novel class of multi-target compounds for serotonin (5-HT) receptors modulation. Our solution integrates complex mechanisms of action of the serotonergic system, with AI-driven structural biology to design compounds targeting multiple serotonin receptor subtypes optimizing therapeutic outcomes. Advances in AI computational chemistry tools enable now the designing of multi-target compounds with precision and selectivity, ensuring efficacy, safety, and scalability.
Team, connections & fundraising — for community members
Join for free to see the founders, connect with them, and view fundraising details.